 | | | | Europe's drugs regulator said on Thursday it had started a program in December to share COVID-19 vaccine and treatment expertise with regulators not part of the European Union, collaborating with them to understand decisions around potential shots or medicines. | | |
| | | The world faces around 4,000 variants of the virus that causes COVID-19, prompting a race to improve vaccines, Britain said on Thursday, as researchers began to explore mixing doses of the Pfizer and AstraZeneca shots. | | |
| | | Malaysia's Solution Group Bhd said on Thursday it has signed a term sheet agreement with the government to supply 3.5 million doses of COVID-19 vaccine jointly developed by China's CanSino Biologics Inc and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences. | | |
| | | Sixteen African countries have shown interest in securing COVID-19 vaccines under an African Union (AU) initiative and the aim is to deliver allocations in the next three weeks, the head of a continental disease control body said on Thursday. | | |
| | | Taiwan will get a share of 1.3 million COVID-19 vaccine shots produced by AstraZeneca Plc from the COVAX global vaccine programme, the government said on Thursday, but without providing a timeframe or further details. | | |
| | | The Palestinians will receive on Thursday 10,000 doses of Russia's Sputnik V vaccine to help jumpstart their inoculation campaign, officials said. | | |
| | | A member of the World Health Organization-led team searching for clues to the origins of COVID-19 in the central Chinese city of Wuhan said work was needed to try to trace genetic elements of the virus in bat caves. | | |
| | | About 21.5% of India's 1.35 billion people may have been infected with COVID-19, according to a government serological survey of more than 35,500 people released on Thursday. | | |
| | | Thailand will import the first doses of AstraZeneca's vaccine from Asia after Europe enforced export controls, the country's health minister said on Thursday. | | |
| | | Governments and developers around the world are exploring the potential use of "vaccine passports" as a way of reopening the economy by identifying those protected against the coronavirus. | | |
| | | Bangladesh's Beximco Pharmaceuticals Ltd said on Thursday the Serum Institute of India (SII) had delayed the first supplies of a COVID-19 vaccine for private sale, instead prioritising government immunisation campaigns. | | |
|
| |
